Positron emission tomography in drug evaluation: Influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-l-dopa in rhesus monkey

This publication has 18 references indexed in Scilit:

• Physiology of Basal Ganglia Disorders: An Overview
  Canadian Journal of Neurological Sciences, 1993
• Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
  Movement Disorders, 1993
• Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study
  Brain Research, 1992
• [ ¹⁸ F]‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)
  Neurology, 1992
• Distribution and Kinetics of 3-O-Methyl-6-[¹⁸F]fluoro-L-DOPA in the Rhesus Monkey Brain
  Journal of Cerebral Blood Flow & Metabolism, 1991
• Reduction of Circulating 3-O-Methyldopa by Inhibition of Gatechol-O-Methyltransferase With OR-611 and OR-462 in Cynomolgus Monkeys
  Clinical Neuropharmacology, 1991
• New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
  Trends in Pharmacological Sciences, 1989
• Clinical Pharmacokinetics of Anti-Parkinsonian Drugs
  Clinical Pharmacokinetics, 1987
• Dopamine visualized in the basal ganglia of living man
  Nature, 1983
• Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma
  Life Sciences, 1980